CSIMarket
 


Grifols Sa  (GRFS)
Other Ticker:  
 
 

GRFS's Income from Cont. Operations Growth by Quarter and Year

Grifols Sa's Income from Cont. Operations results by quarter and year




GRFS Income from Cont. Operations (in millions $) FY 2020 FY 2019 FY 2018 FY 2017
IV Quarter December 794.07 726.48 665.73 661.31
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   794.07 726.48 665.73 661.31



GRFS Income from Cont. Operations forth quarter 2020 Y/Y Growth Comment
Grifols Sa showed record Income from Cont. Operations improvement in the forth quarter with 9.3% from the forth quarter 2019, to $ 794.07 millions.

Looking into forth quarter results within Major Pharmaceutical Preparations industry 21 other companies have achieved higher Income from Cont. Operations growth. While Grifols Sa' s Income from Cont. Operations increase of 9.3% ranks overall at the positon no. 855 in the forth quarter.




GRFS Income from Cont. Operations ( Y/Y Growth %) 2020
2019 2018 2017
IV Quarter December 9.3 % 9.13 % 0.67 % -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   9.3 % 9.13 % 0.67 % -

Financial Statements
Grifols Sa's forth quarter 2020 Income from Cont. Operations $ 794.07 millions GRFS's Income Statement
Grifols Sa's forth quarter 2019 Income from Cont. Operations $ 726.48 millions Quarterly GRFS's Income Statement
New: More GRFS's historic Income from Cont. Operations Growth >>


GRFS Income from Cont. Operations (Quarter on Quarter Growth %)

2020
2019 2018 2017
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   9.3 % 9.13 % 0.67 % -




Income from Cont. Operations forth quarter 2020 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #22
Healthcare Sector #78
Overall #855

Income from Cont. Operations Y/Y Growth Statistics
High Average Low
9.3 % 9.21 % 9.12 %
(Dec 31 2020)   (Dec 31 2019)
Income from Cont. Operations forth quarter 2020 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #22
Healthcare Sector #78
Overall #855
Income from Cont. Operations Y/Y Growth Statistics
High Average Low
9.3 % 9.21 % 9.12 %
(Dec 31 2020)   (Dec 31 2019)

Income from Cont. Operations by Quarter for the Fiscal Years 2017, 2018, 2019, 2020

Grifols Sa's Q/Q Income from Cont. Operations Growth


Income from Cont. Operations Q/Q Growth Statistics
High Average Low
-100 % -100 % -100 %
0  


GRFS's IV. Quarter Q/Q Income from Cont. Operations Comment


Income from Cont. Operations Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #0
Income from Cont. Operations Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #0
Income from Cont. Operations Q/Q Growth Statistics
High Average Low
-100 % -100 % -100 %
0  


GRFS's IV. Quarter Q/Q Income from Cont. Operations Comment


Grifols Sa's 12 Months Income from Cont. Operations Growth Year on Year


Income from Cont. Operations TTM Growth

12 Months Ending
(Dec 31 2020)
12 Months Ending
(Dec 31 2019)
12 Months Ending
12 Months Ending
12 Months Ending
Cumulative Income from Cont. Operations 12 Months Ending $ 794.07 $ 726.48 $ 0.00 $ 0.00 $ 0.00
Y / Y Income from Cont. Operations Growth (TTM) 9.3 % 9.12 % - - -
Year on Year Income from Cont. Operations Growth Overall Ranking # 805 # 0 # 0 # 0 # 1054
Seqeuential Income from Cont. Operations Change (TTM) 9.3 % 9.12 % - - -
Seq. Income from Cont. Operations Growth (TTM) Overall Ranking # 875 # 0 # 0 # 0 # 755




Cumulative Income from Cont. Operations growth Comment
With 9.3% annual Income from Cont. Operations growth, Grifols Sa would report a record annual Income from Cont. Operations improvement if the fiscal year would end on Dec 31 2020.

In the Healthcare sector 76 other companies have achieved higher trailing twelve month Income from Cont. Operations growth. While Income from Cont. Operations growth total ranking has deteriorated compare to previous quarter from 0 to 805.

Income from Cont. Operations TTM Q/Q Growth Statistics
High Average Low
9.3 %
9.21 %
9.12 %
 

Income from Cont. Operations TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 22
Healthcare Sector # 77
Overall # 805

Income from Cont. Operations TTM Y/Y Growth Statistics
High Average Low
9.3 %
9.21 %
9.12 %
 


Income from Cont. Operations TTM Q/Q Growth Company Ranking
Within: No.
Industry # 22
Sector # 79
S&P 500 # 875
Cumulative Income from Cont. Operations growth Comment
With 9.3% annual Income from Cont. Operations growth, Grifols Sa would report a record annual Income from Cont. Operations improvement if the fiscal year would end on Dec 31 2020.

In the Healthcare sector 76 other companies have achieved higher trailing twelve month Income from Cont. Operations growth. While Income from Cont. Operations growth total ranking has deteriorated compare to previous quarter from 0 to 805.

Income from Cont. Operations TTM Q/Q Growth Statistics
High Average Low
9.3 %
9.21 %
9.12 %
 


Income from Cont. Operations TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 22
Healthcare Sector # 77
Overall # 805

Income from Cont. Operations TTM Y/Y Growth Statistics
High Average Low
9.3 %
9.21 %
9.12 %
 


Income from Cont. Operations TTM Q/Q Growth Company Ranking
Within: No.
Industry # 22
Sector # 79
S&P 500 # 875




Other Income from Cont. Operations Growth
Major Pharmaceutical Preparations Industry Income from Cont. Operations Growth Trends and Statistics
Healthcare Sector Income from Cont. Operations Growth Statistics
Income from Cont. Operations Growth Trends for overall market
GRFS's Income from Cont. Operations Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Income from Cont. Operations Growth
Lowest Ranking Income from Cont. Operations Growth
Income from Cont. Operations Growth for GRFS's Competitors
Income from Cont. Operations Growth for Grifols Sa's Suppliers
Income from Cont. Operations Growth for GRFS's Customers

You may also want to know
GRFS's Annual Growth Rates GRFS's Profitability Ratios GRFS's Asset Turnover Ratio GRFS's Dividend Growth
GRFS's Roe GRFS's Valuation Ratios GRFS's Financial Strength Ratios GRFS's Dividend Payout Ratio
GRFS's Roa GRFS's Inventory Turnover Ratio GRFS's Growth Rates GRFS's Dividend Comparisons



Companies with similar Income from Cont. Operations improvement for the quarter ending Dec 31 2020 within Healthcare SectorY/Y Change %Income from Cont. Operations for the quarter ending Dec 31 2020
Cellect Biotechnology Ltd 15.63%$ 15.628 millions
Intricon Corporation15.63%$ 15.625 millions
Novocure Limited15.42%$ 15.423 millions
Mettler Toledo International Inc12.22%$ 12.216 millions
Resmed Inc 11.81%$ 11.809 millions
Petmed Express Inc11.27%$ 11.272 millions
Edwards Lifesciences Corporation10.46%$ 10.457 millions
Steris Plc9.48%$ 9.479 millions
Grifols Sa9.30%$ 9.303 millions
Phibro Animal Health Corp7.63%$ 7.626 millions
Prestige Consumer Healthcare Inc 6.70%$ 6.700 millions
Haemonetics Corporation6.65%$ 6.647 millions


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

HZAC's Profile

Stock Price

HZAC's Financials

Business Description

Fundamentals

Charts & Quotes

HZAC's News

Suppliers

HZAC's Competitors

Customers & Markets

Economic Indicators

HZAC's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071